Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Macdonald

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Molecular Psychiatry|December 16, 2025
Fshr gene depletion prevents recognition memory loss, fat accrual and bone loss in Alzheimer's miceUliana Cheliadinova, Steven Sims, Funda Korkmaz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 2026
From discovery to therapeutic development of monoclonal antibodiesSatish Rojekar, Amol Gholap, Anusha R Pallapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2020
First-in-class humanized FSH blocking antibody targets bone and fatSakshi Gera, Damini Sant, Shozeb Haider, et al.
The Journal of Clinical Investigation|July 15, 2025
Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease modelsAnusha R Pallapati, Funda Korkmaz, Satish Rojekar, et al.
Elife|September 20, 2022
FSH-blocking therapeutic for osteoporosisSakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Molecular Psychiatry|December 16, 2025
Fshr gene depletion prevents recognition memory loss, fat accrual and bone loss in Alzheimer's miceUliana Cheliadinova, Steven Sims, Funda Korkmaz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 2026
From discovery to therapeutic development of monoclonal antibodiesSatish Rojekar, Amol Gholap, Anusha R Pallapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2020
First-in-class humanized FSH blocking antibody targets bone and fatSakshi Gera, Damini Sant, Shozeb Haider, et al.
The Journal of Clinical Investigation|July 15, 2025
Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease modelsAnusha R Pallapati, Funda Korkmaz, Satish Rojekar, et al.
Elife|September 20, 2022
FSH-blocking therapeutic for osteoporosisSakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
Pageof 4